Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2024-08-01 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Appointment
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing the authorized persons responsible for determining materiality of events and making disclosures under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It lists key executives and their contact details for compliance purposes. The document does not contain any financial data, report content, or detailed analysis. It is a regulatory disclosure about compliance and authorized contacts rather than a financial report or announcement of results. The document length is short (1991 characters) and it is a compliance disclosure under SEBI regulations, fitting best under Regulatory Filings (RNS).
2024-08-01 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing a change in the Company Secretary and Compliance Officer of Themis Medicare Limited. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content details the appointment of a new Company Secretary and Compliance Officer effective 1st August 2024, including a brief profile of the appointee. The document length is 4205 characters, which is relatively short and focused solely on management change information. There are no financial statements, earnings data, or other report contents. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in senior management or board members.
2024-08-01 English
Retirement
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing a change in the Company Secretary and Compliance Officer due to retirement. It references compliance with SEBI Listing Regulations, specifically Regulation 30, which mandates disclosure of material events including changes in key managerial personnel. The content includes the retirement date, the name of the outgoing officer, and a brief profile section (not applicable here). There are no financial statements, earnings data, or report attachments. The document is an announcement of a management change rather than a full management report or annual filing. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming it is not a report or announcement of a report publication.
2024-07-31 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of un-audited standalone and consolidated financial results for the quarter ended June 30, 2024. It references compliance with SEBI Listing Regulations and includes a newspaper advertisement extract of the financial results. The document does not contain the full financial statements or detailed financial analysis but rather announces the publication of quarterly financial results. This fits the description of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. The document length is 15,000 characters, which is substantial, but the content is focused on announcing the results publication and providing newspaper extracts, not the full report itself. Therefore, the appropriate classification is Earnings Release (ER).
2024-07-29 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges (BSE and NSE) with a submission date of 26th July 2024. It explicitly states it is an 'Investors’ Presentation' and includes detailed financial highlights for Q1 FY25, management commentary, consolidated quarterly and full-year financial data, company overview, and strategic focus. The document is about 15,000 characters long, which is substantial and contains detailed financial and operational information typical of an investor presentation. There is no indication that this is a full annual report (10-K) or an interim report (IR) with full financial statements, nor is it a regulatory filing or announcement of a report. The content matches the description of an Investor Presentation (IP) which focuses on financials, strategy, and market position for investors.
2024-07-27 English
Outcome of Board Meeting
Regulatory Filings
2024-07-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.